EDGAR Filing Documents for 0001628280-18-006045

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001628280-18-006045

Filing Date

2018-05-07

Accepted

2018-05-07 16:02:12

Documents

Period of Report

2018-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	6-K Q1 2018 AEZS	q1-2018x6k.htm	6-K	21835
2	EXHIBIT 99.1 FINANCIAL	q1-2018xex991fsxquarterly.htm	EX-99.1	667622
3	EXHIBIT 99.2 MD&A	q1-2018xex992mdaxquarterly.htm	EX-99.2	313593
4	EXHIBIT 99.3 CEO CERT	q1-2018xex993certification.htm	EX-99.3	12600
5	EXHIBIT 99.4 CFO CERT	q1-2018xex994certification.htm	EX-99.4	12569
6		aeternazentarislogoa86.jpg	GRAPHIC	14150
7		outsourcea04.jpg	GRAPHIC	57688
	Complete submission text file	0001628280-18-006045.txt		1128550

Mailing Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2

Business Address C/O STIKEMAN ELLIOTT LLP 1155 RENE-LEVESQUE BLVD. WEST, 41ST FLR MONTREAL A8 H3B 3V2 843-900-3201

Aeterna Zentaris Inc. (Filer) CIK: 0001113423 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38064 | Film No.: 18811207
SIC: 2834 Pharmaceutical Preparations